<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">8404176</journal-id>
<journal-id journal-id-type="pubmed-jr-id">1462</journal-id>
<journal-id journal-id-type="nlm-ta">J Biomol Struct Dyn</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Biomol. Struct. Dyn.</journal-id>
<journal-title-group>
<journal-title>Journal of biomolecular structure &amp; dynamics</journal-title>
</journal-title-group>
<issn pub-type="ppub">0739-1102</issn>
<issn pub-type="epub">1538-0254</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29663862</article-id>
<article-id pub-id-type="pmc">6235728</article-id>
<article-id pub-id-type="doi">10.1080/07391102.2018.1465854</article-id>
<article-id pub-id-type="manuscript">NIHMS1508363</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Dynamics and Structural Stability Effects of Germline <italic>PTEN</italic> Mutations Associated with Cancer versus Autism Phenotypes</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Smith</surname>
<given-names>Iris Nira</given-names>
</name>
<!--<email>smithi4@ccf.org</email>-->
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Thacker</surname>
<given-names>Stetson</given-names>
</name>
<!--<email>thackes@ccf.org</email>-->
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="aff" rid="A5">e</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jaini</surname>
<given-names>Ritika</given-names>
</name>
<!--<email>jainir@ccf.org</email>-->
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="aff" rid="A4">d</xref>
<xref ref-type="aff" rid="A5">e</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Eng</surname>
<given-names>Charis</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="aff" rid="A2">b</xref>
<xref ref-type="aff" rid="A3">c</xref>
<xref ref-type="aff" rid="A4">d</xref>
<xref ref-type="aff" rid="A5">e</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>a</label>Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Genomic Medicine Institute, NE-50, Cleveland Clinic, Lerner Research Institute, 9500 Euclid Avenue, Cleveland, OH 44195; Tel: (216) 444-3900</aff>
<aff id="A2"><label>b</label>Taussig Cancer Institute, Cleveland Clinic, Genomic Medicine Institute, NE-50, Cleveland Clinic, Lerner Research Institute, 9500 Euclid Avenue, Cleveland, OH 44195; Tel: (216) 444-3900</aff>
<aff id="A3"><label>c</label>Department of Genetics and Genome Sciences, Genomic Medicine Institute, NE-50, Cleveland Clinic, Lerner Research Institute, 9500 Euclid Avenue, Cleveland, OH 44195; Tel: (216) 444-3900</aff>
<aff id="A4"><label>d</label>Germline High Risk Cancer Focus Group, Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Genomic Medicine Institute, NE-50, Cleveland Clinic, Lerner Research Institute, 9500 Euclid Avenue, Cleveland, OH 44195; Tel: (216) 444-3900</aff>
<aff id="A5"><label>e</label>Cleveland Clinic Lerner College of Medicine, Genomic Medicine Institute, NE-50, Cleveland Clinic, Lerner Research Institute, 9500 Euclid Avenue, Cleveland, OH 44195; Tel: (216) 444-3900</aff>
<author-notes>
<corresp id="CR1"><bold>Correspondence to</bold>: Charis Eng, MD, PhD, Genomic Medicine Institute, NE-50, Cleveland Clinic Lerner Research Institute, 9500 Euclid Avenue, Cleveland, OH 44195, <email>engc@ccf.org</email> Tel: (216) 444-3440</corresp>
<fn fn-type="COI-statement" id="FN1">
<p id="P36">Disclosure statement</p>
<p id="P37">The authors declare no relevant conflict of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>5</day>
<month>10</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>14</day>
<month>5</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>4</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>4</month>
<year>2020</year>
</pub-date>
<volume>37</volume>
<issue>7</issue>
<fpage>1766</fpage>
<lpage>1782</lpage>
<!--elocation-id from pubmed: 10.1080/07391102.2018.1465854-->
<abstract id="ABS1">
<p id="P1">Individuals with germline mutations in the tumor suppressor gene phosphatase and tensin homolog (<italic>PTEN</italic>), irrespective of clinical presentation, are diagnosed with <italic>PTEN</italic> hamartoma tumor syndrome (PHTS). PHTS confers a high risk of breast, thyroid, and other cancers or autism spectrum disorder (ASD) with macrocephaly. It remains unclear why mutations in one gene can lead to seemingly disparate phenotypes. Thus, we sought to identify differences in ASD vs. cancer-associated germline <italic>PTEN</italic> missense mutations by investigating putative structural effects induced by each mutation. We utilized a theoretical computational approach combining <italic>in silico</italic> structural analysis and molecular dynamics (MD) to interrogate 17 selected mutations from our patient population: six mutations were observed in patients with ASD (only), six mutations in patients with PHTS-associated cancer (only), four mutations shared across both phenotypes, and one mutation with both ASD and cancer. We demonstrate structural stability changes where all six cancer-associated mutations showed a global decrease in structural stability and increased dynamics across the domain interface with a proclivity to unfold, mediating a closed (inactive) active site. In contrast, five of the six ASD-associated mutations showed localized destabilization that contribute to the partial opening of the active site. Our results lend insight into distinctive structural effects of germline <italic>PTEN</italic> mutations associated with PTEN-ASD vs. those associated with PTEN-cancer, potentially aiding in identification of the shared and separate molecular features that contribute to autism or cancer, thus, providing a deeper understanding of genotype-phenotype relationships for germline <italic>PTEN</italic> mutations.</p>
</abstract>
<kwd-group>
<kwd>PTEN</kwd>
<kwd>Cancer</kwd>
<kwd>Autism</kwd>
<kwd>Molecular Dynamics Simulations</kwd>
<kwd>Protein Structure Stability</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>